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Abstract: Assisted reproductive technologies (ART) are the treatment of choice for some infertile
couples and even though these procedures are generally considered safe, children conceived by ART
have shown higher reported risks of some perinatal and postnatal complications such as low birth
weight, preterm birth, and childhood cancer. In addition, the frequency of some congenital imprinting
disorders, like Beckwith–Wiedemann Syndrome and Silver–Russell Syndrome, is higher than ex-
pected in the general population after ART. Experimental evidence from animal studies suggests that
ART can induce stress in the embryo and influence gene expression and DNA methylation. Human
epigenome studies have generally revealed an enrichment of alterations in imprinted regions in chil-
dren conceived by ART, but no global methylation alterations. ART procedures occur simultaneously
with the establishment and maintenance of imprinting during embryonic development, so this may
underlie the apparent sensitivity of imprinted regions to ART. The impact in adulthood of imprinting
alterations that occurred during early embryonic development is still unclear, but some experimental
evidence in mice showed higher risk to obesity and cardiovascular disease after the restriction of
some imprinted genes in early embryonic development. This supports the hypothesis that imprinting
alterations in early development might induce epigenetic programming of metabolism and affect
long-term health. Given the growing use of ART, it is important to determine the impact of ART in
genomic imprinting and long-term health.
Keywords: genomic imprinting; assisted reproductive technology; DNA methylation; epigenetic
reprogramming; long-term health
1. Introduction
In the last century, fertility rates all over the world have experienced a significant de-
cline. Estimations suggest that the decline will continue and the fertility rate will be below
the replacement rate by 2060 [1,2]. The causes of this decline are multiple including new life
style choices [3], but also an increased rate of infertility [4]. Infertility is commonly caused
by lack of regular ovulation, blocked or damaged fallopian tubes, endometriosis, lack of
sperm, and abnormal sperm [4]. For example, sperm counts have declined between 50 and
60% between 1973 and 2011 in North America, Europe, Australia, and New Zealand [5].
Some studies have suggested an association between some environmental stressors (like
pesticides, diet, stress, smoking, pollution, and BMI) and sperm count decline, menstrual
cycle alterations, and abnormal oocyte maturation [6–14]. In this context, assisted reproduc-
tive technologies (ART) may become the preferred option for many infertile couples. ART
procedures include the conventional in-vitro fertilisation (IVF) and the intracytoplasmic
sperm injection (ICSI) but also controlled ovarian hyperstimulation (COH), oocyte retrieval,
embryo culture, and embryo transfer. Since its introduction in 1978, more than eight million
babies have been born from IVF around the world. The number of ART cycles per year is
estimated in more than two million, leading to more than 500,000 babies per year around
the world [15,16]. The International Committee for ART reported in 2016 an average in-
crease in ART cycles per year of 9.1% [16]. Since the beginning, ART procedures have been
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controversial and, although ART procedures are considered safe, epidemiological studies
have reported an increased incidence of obstetric, perinatal, and postnatal complications in
children conceived by ART [17–20]. Animal studies have also observed alterations in em-
bryonic development, gene expression, and DNA methylation after ART [21]. In humans,
epigenome studies have generally revealed no global DNA methylation alterations, but
have described some regions to be especially sensitive to the stress induced by ART like
imprinted regions [22]. Besides, children conceived by ART have shown higher frequency
of developmental disorders caused by the disruption of genomic imprinting than children
conceived naturally [20]. However, only five out of eight epigenome studies identified an
enrichment of alterations at imprinted regions, which might be caused by the small sample
size analysed and the sensitivity of the method used. Therefore, despite the evidence of
genomic imprinting alterations after ART in humans, animal models, and farm animals,
it is still unclear how ART procedures can affect genomic imprinting and to what extent.
Given the critical role of imprinted genes in growth, development, and metabolism and the
possible influence of these alterations during embryonic development in long-term health,
it is crucial to determine the impact of ART in genomic imprinting.
This review summarises epidemiological evidence of phenotypic alterations in indi-
viduals conceived by ART and experimental evidence of the impact of the stress induced by
ART in embryonic development. In addition, experimental evidence of DNA methylation
alterations at imprinted regions and genome-wide level in individuals conceived by ART
are discussed. Finally, current knowledge of the potential influence of genomic imprinting
alterations induced by ART in postnatal growth and development and risks of long-term
health conditions is summarised.
2. Phenotypic Outcomes Described in ART Children
The global pregnancy rate after ART was estimated to be approximately 26%. Among
them, around 20% suffered early pregnancy loss [16]. From the pregnancies that reached
term, epidemiological data indicate a higher risk of obstetric and perinatal complications,
postnatal growth and development alterations, cancer risk and metabolic alterations in
comparison with naturally conceived (Table 1).
Obstetric and perinatal complications have been widely studied in large cohorts of
samples. The largest study compared 11,347 children conceived by ART with 571,914 children
conceived naturally, finding significant low birth weight and preterm birth, with odd ratios
(OR) of 1.13 (95%CI, 1.02–1.25) and 1.15 (95%CI, 1.06–1.25), respectively (Table 1) [23].
The largest register for ART published in 2020 also reported 1.1% extreme preterm birth
(20–27 gestational weeks at delivery) and 2.2% very premature birth (28–32 gestational
weeks at delivery) in ART singletons [24]. These results were also confirmed by other
studies (Table 1). Large postnatal studies in children conceived by ART revealed increased
risk to cerebral palsy (OR 2.22; 95% CI, 1.35–3.63) [25] and no increased risk of autism
spectrum disorders [25–30]. However, a recent meta-analysis of 11 studies with large
sample size found increased risk of autism spectrum disorders in children conceived by
ART (RR 1.35; 95% CI, 1.09–1.68) [28]. The postnatal growth and development did not show
significant differences [31–37], except for a significant gain of weight, height, and BMI in
late infancy [38]. The risk of childhood cancer in children conceived by ART is controversial.
The larger and more recent studies have found an increased risk for hepatoblastoma (SIR,
3.64; 95% CI, 1.34–7.93), rhabdomyosarcoma (SIR, 2.62; 95% CI, 1.26–4.82), central nervous
system tumours (OR 1.44; 95% CI, 1.01–2.05), and malignant epithelial neoplasms (OR 2.03;
95% CI, 1.06–3.89) in children conceived by ART [39,40]. In addition to this, a meta-analysis
published in 2020 including 27 studies revealed significant increased risk to paediatric
cancer after frozen embryo transfer but no increased risk after other fertility treatments [41].
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Table 1. Obstetric, perinatal, and postnatal phenotypic outcomes in individuals conceived by ART.
Cases Controls No. Cases No. Ctrls YOB/Age Outcomes References
Obstetric
and perinatal
IVF GP 3305 1,505,724 1982–1995 Very low birth weight (<1500 g) (4.39; 95% CI,
3.62–5.32) Very preterm birth (<32 weeks)
(3.54; 95% CI, 2.90–4.32)
Bergh et al., 1999
IVF/ICSI SC 237 338 1998–2003 Preterm birth (P < 0.01) Buckett et al., 2007
IVF/ICSI SC 742 16,525 1989–2006 Stillbirth (4.08; 95% CI, 2.11–7.93) Wisborg et al., 2010
IVF/ICSI SC 2876 4882 1994–2006 Low birth weight (1.4; 95% CI, 1.1–1.7) and
preterm birth (1.3; 95% CI, 1.1–1.6)
Henningsen et al., 2011
IVF SC 11,347 571,914 2002–2006 Low birth weight (1.13; 95% CI, 1.02–1.25)
and preterm birth (1.15; 95% CI, 1.06–1.25)
Sazonova et al., 2011
ART SC 4333 295,220 1986–2002 Low birth weight (P < 0.001) and preterm
birth (P < 0.001)
Davies et al., 2012
IVF/ICSI SC 1813 1813 1999–2007 Association between maternal characteristics
and lower birth weight
Seggers et al., 2016
IVF SC 1778 33,555 2005–2014 Low birth weight (RR 1.47; 95% CI 1.20–1.80)
and preterm birth (RR 1.51; 95% CI 1.28–1.78)




IVF SC 66 66 12–45
months
No significant differences in developmental
indices
Brandes et al., 1992
IVF GP 258 6–13 years No significant differences in surgical
procedures, malformation, height and
weight, and school performance
Olivennes et al., 1997
IVF + CE SC 158/160 156 0–18 months No significant differences in growth features,
major malformations and the prevalence of
chronic diseases
Wennerholm et al., 1998




ICSI SC 150 147 8 years No significant differences in pubertal staging,
neurological examination, remedial therapy
or surgery or hospitalization
Belva et al., 2007
IVF SC-SFP 193 199 0–4 years Increased risk of lower weight, height and
BMI at 3 months. Greater gain in weight
(P < 0.001), height (P = 0.013) and BMI
(P = 0.029) during late infancy (3 mo-1y)
Ceelen et al., 2009
IVF/ICSI SC 309 173 0–12 years No significant differences in head
circumference, height and weight
Basatemur et al., 2010
ART SC 3617 35,848 >4 years An increased risk of cerebral palsy (2.30;
95% CI, 1.12–4.73)
Zhu et al., 2010
ART SC 33,139 555,728 4–13 years No increased risk of autism spectrum
disorders
Hvidtjorn et al., 2011
ART SC 4333 295,220 <5 years An increased risk of cerebral palsy (2.22;
95%CI, 1.35–3.63)
Davies et al., 2012
ART SC 349 1847 >2 years No increased risk of autism spectrum
disorders
Grether et al., 2013
ART SC 4164 16,582 2–16 years No increased risk of autism spectrum
disorders
Lehti et al., 2013
ART/OI/II SC 968 2471 0–3 years No significant differences in growth, motor
and cognitive development
Yeung et al., 2016
IVF/ICSI SC 2914 208,746 1994–2002 An increased risk of cerebral palsy (2.60;
95% CI, 1.60–4.00)
Goldsmith et al., 2017
ART SC 46,249 10,702,377 Meta-analysis 11 studies. An increased risk
of autism spectrum disorders (RR1.35;
95% CI, 1.09–1.68)
Li et al., 2017
Cancer risk IVF GP 3305 1,505,724 0–14 years No increased risk for childhood cancer Bergh et al., 1999
IVF GP 332 5–8 years No increased risk for childhood cancer Lerner-Geva et al., 2000
ART GP 5249 0–15 years Increased risk of childhood cancer (SIR, 1.39;
95% CI, 0.62–3.09)
Bruisma et al., 2000
ART SC-SFP 9484 7532 1–14 years No increased risk for childhood cancer Klip et al., 2001
IVF GP 26,692 >2 years Increased risk of childhood cancer (SIR,1.42;
95% CI,1.09–1.87)
Kallen et al., 2010
IVF GP 106,013 0–15 years Increased risk of hepatoblastoma (SIR, 3.64;
95% CI, 1.34–7.93) and rhabdomyosarcoma
(SIR, 2.62; 95% CI, 1.26–4.82)
Williams et al., 2013
ART SC 61,693 351,536 9–14 years Increased risk for central nervous system
tumours (1.44; 95% CI, 1.01–2.05) malignant
epithelial neoplasms (2.03; 95% CI, 1.06–3.89)






1,393,284 Meta-analysis 27 studies. Increased risk to
childhood cancer after FET (1.37; 95% C,
1.04–1.81).





GP 69 71 4–10 years ↑HDL, ↓triglycerides, ↑IGF-2, ↑height.
Normal body fat and fasting glucose
Miles et al., 2007
IVF SC-SFP 233 233 8–18 years ↑ Body fat, ↑ blood pressure, ↑ fasting
glucose
Ceelen et al., 2007 & 2008
IVF SC 106 68 4–14 years ↑Blood pressure, ↑triglycerides, ↑TSH.
Normal fasting glucose
Sakka et al., 2009 & 2010
ICSI GP 217 223 14 years ↑ Body fat normal blood pressure Belva et al., 2012b
ART SC 65 57 7–18 years Systemic and pulmonary vascular
dysfunction
Scherrer et al., 2012
IVF SC 10 10 2–4 weeks Subclinical hypothyroidism Onal et al., 2012
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Table 1. Cont.
Cases Controls No. Cases No. Ctrls YOB/Age Outcomes References




IVF SC-SFP 63 79 4 years ↑ Blood pressure, ↑body fat La Bastide-Van Gemert
et al., 2013
IVF SC-FP 14 20 17–26 years ↓Peripheral insulin sensitivity Chen et al., 2014
IVF/ICSI SC-FP 28 220 5–6 years ↑Fasting glucose Pontesilli et al., 2015
ART SC 54 54 7–18 years Right ventricular dysfunction von Arx et al., 2015
IVF/ICSI SC 2112 4096 1 month–
12 years
Meta-analysis 19 studies. ↑ blood pressure ↓
LDL ↑fasting insulin levels. Suboptimal
cardiac diastolic function and ↑ vessel
thickness.
Guo et al., 2017
ART, assisted reproductive technologies; IVF, in vitro fertilisation; ICSI, intracytoplasmic sperm injection; OI, ovulation induction; II,
intrauterine insemination; SC, spontaneous conception; GP, general population; SFP, subfertile parent; FP, fertile parent; CE, cryopreserved
embryos; CI, confidence intervals; RR, prevalence proportion ratios; IGF, insulin-like growth factor; BMI, body mass index; HR, hazard ratio;
SIR, standardized incidence ratio; BMD, bone mineral density; BMI, body mass index; CVD, cardiovascular disease; HDL, high-density
lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; TG, triglyceride; SGA, small for gestational age; TSH, thyroid stimulating
hormone. Furthermore, children and adolescents conceived by ART showed increased risk of metabolic and vascular alterations such
as higher body fat, blood pressure, hypothyroidism, and vascular dysfunction (Table 1) [42–53]. A meta-analysis of 19 studies reported
an increased risk of higher blood pressure and fasting insulin levels, lower LDL, and suboptimal cardiac diastolic function with higher
vessel thickness after ART [54]. The presence of these metabolic alterations in childhood and adolescence may predispose them to chronic
diseases like obesity, type 2 diabetes, and cardiovascular disorder in adulthood [55,56].
3. ART Can Induce Stress in the Embryo
The complications described in ART children are probably caused by the significant
differences between in vitro and in vivo environments. The development of the embryo
in the female reproductive tract involves the exposure to multiple hormones, nutrients,
growth factors, and cytokines and well-maintained environmental conditions [45]. In con-
trast, ART procedures require the extraction and in vitro culture of gametes and embryos,
the manipulation through pipetting, and the exposure to temperature, oxygen, and pH
oscillations [57]. Besides, these stressors can occur individually or simultaneously [58] and
the stress induced in the embryo can affect developmental rates and embryo quality [21].
ART procedures take place during gametogenesis, fertilisation, and early embryo
development including pre-implantation and implantation stages (Figure 1).
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Therefore, ovarian hyperstimulation (COH) and gamete freezing occur during game-
togenesis, IVF during fertilisation, embryo culture and freezing during preimplantation
and preimplantation genetic diagnosis (PGD), and assisted hatching and embryo transfer
during the implantation stage [59]. The ovarian hyperstimulation or superovulation is
a common procedure used to obtain a large number of oocytes to increase ART success
rates. Generally, superovulation produces oocytes morphologically and functionally pre-
served [60,61], however, adverse effects like alterations in oocyte maturation rate have
been reported [62,63]. Superovulation in mice can produce a delay in embryonic and
foetal development and decreases implantation rates [64,65]. Likewise, superovulation
was associated with alterations in the expression of some genes in the oocyte, producing a
lower quality of oocytes and embryos in mice [66]. Superovulation is usually followed by
in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). The stress induced
specifically by these is difficult to estimate because in a normal situation, these are preceded
by superovulation and followed by in vitro culture. Nevertheless, mice studies described
slightly delayed in prenatal and postnatal development with lower birth weight and
smaller placentas than those naturally conceived [53,67]. Later in development, IVF adult
mice showed impaired glucose tolerance, increased fasting glucose levels, and reduced
insulin-stimulated Akt phosphorylation in the liver [53]. These results are similar to the
ones obtained in humans, suggesting that these alterations may be caused by ART proce-
dures. ICSI can also have additional complications. In this procedure, sperm is directly
injected into the egg, thus avoiding the natural selection of the sperm based on motility,
acrosome activation, and membrane fusion of gametes. The alterations in the sperm can
lead to additional alterations in the embryonic development [68,69] and might explain
why ICSI is the fertilisation procedure that induced the highest number of differentially
expressed genes [22].
After in vitro fertilisation, the fertilized egg is cultured in vitro. This procedure has
been widely used in animal models, farm animals, and humans, however, culture condi-
tions are still not completely optimised. The two main factors that can affect embryo devel-
opment during in vitro culture (IVC) are the culture conditions and the culture medium
composition. Therefore, mouse blastocysts after in vitro culture in different culture con-
ditions show significant differences in expression levels, with an enrichment in genes
associated with metabolism [70]. Among the culture media tested, Whitten’s medium at
20% oxygen is the most stressful culture condition inducing a high number of differentially
expressed genes [22]. Apart from gene expression changes, some studies have also reported
epigenetic changes after IVC, possibly caused by alterations in epigenetic reprogramming
during the transition from the zygote to blastocyst stage (Figure 1) [21,71–74].
4. ART, Epigenetic Reprogramming, and Genomic Imprinting
During embryonic development, DNA methylation plays a crucial role in cell differen-
tiation, sex chromosome dosage compensation, retrotransposons repression, and genomic
imprinting, but it is also essential for the success of sexual reproduction in mammals [75].
During gametogenesis, primordial germ cells erase somatic DNA methylation signatures
and establish sex-specific and germ cell-specific epigenetic signatures (Figure 1). This first
wave of epigenetic reprogramming is required to establish the appropriate imprinting
marks in germ cells [76]. Maternal marks are established in oocyte and paternal marks in
sperm (Figure 1). After fertilisation, the zygote requires the erasure of DNA methylation
marks to initiate the embryonic development. In this second wave of epigenetic repro-
gramming, genomic imprinting, transposable elements, and metastable epialleles should
be protected from demethylation (Figure 1) [76]. ART procedures occur simultaneously to
this extensive epigenetic reprogramming and the stress produced by ART might affect the
establishment and/or maintenance of genomic imprinting.
Genomic imprinting is an epigenetic process that is known to affect the expression
of more than 100 human genes with crucial roles in growth, metabolism, and develop-
ment including the control of embryonic growth, placenta development, and post-natal
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development and metabolism [77–80]. Genomic regions controlled by genomic imprinting
present differential imprinting marks to distinguish maternal and paternal alleles. These
marks cause monoallelic expression in a parent-of-origin-specific manner. The differential
epigenetic marks that control allele-specific expression are established during gametoge-
nesis in male and female germline (Figure 2). Imprinted genes are usually organised in
clusters called imprinted domains, which share regulatory elements such as differentially
methylated regions (DMRs) and imprinting control region (ICR) (Figure 2). The disruption
of a single or multiple germline DMRs (gDMRs) affecting the expression of imprinted
genes can cause congenital imprinting disorders (CIDs). CIDs are a group of developmen-
tal disorders with overlapping clinical features such as growth abnormalities, metabolic
alterations, and developmental delay [81]. Genomic imprinting alterations have also been
implicated in complex disorders such as autism and non-syndromic embryonal tumours
(e.g., Wilms tumour) [82,83].
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In this case, both gDMRs are also considered as imprinting control regions (ICRs). This region is associated with two
congenital imprinting disorders, BWS and SRS. The loss-of-methylation of ICR2 or the gain-of-methylation of ICR1 causes
BWS, an overgrowth disorder. In contrast, the loss-of-methylation of ICR1 causes SRS, a growth retardation disorder. DMR,
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Errors in the establishment and/or maintenance of the imprinting have been found
in hydatidiform mole [85–87], miscarriages, congenital imprinting disorders (CIDs), and
multi-locus imprinting disturbances (MLIDs) [88–90]. Women with mutations in NLRP7
showed hydatidiform moles and miscarriages, caused by loss of methylation at multiple
ICRs [86]. Likewise, maternal mutations in components of subcortical maternal complex
(SCMC) such as NLRP5 and NLRP2 have been described in CID cases with MLIDs [91].
SCMC components are expressed in mammalian oocytes and early embryos before zygote
genome activation and might be responsible for the availability of the components required
for the protection of genomic imprinting during epigenetic reprogramming [92]. One
important component of this protection is ZFP57, a zygotic factor in humans, which
recognizes methylated CpG in the TGCCmeGC hexamer consensus motif located in some
ICRs. ZFP57 recruits TRIM28 and KAP1 complexes, which promote the recruitment of
SETDB1 and DNMT1 to maintain the methylation at those ICRs [93]. Recessive mutations
in ZFP57 have been identified in transient neonatal diabetes cases, a congenital imprinting
disorder, with a specific pattern of MLIDs [94,95].
Consequently, the disruption of the establishment and maintenance of imprinting
marks by the stress induced by ART might affect normal embryonic development and
future health.
5. Genomic Imprinting Alterations after ART
Numerous studies have reported an increased risk of congenital imprinting disorders
in children conceived by ART [20,96,97]. In 2002, Cox et al. reported two Angelman
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syndrome (AS) cases conceived by ICSI with both loss-of-methylation (LOM) at maternal
SNURF:TSS DMR, one with complete LOM and the other one with partial LOM [98].
Interestingly, the frequency of this epimutation in AS conceived naturally was less than
5% of cases, suggesting a possible link between ICSI and AS. In 2003, three different studies
in three different countries, the UK, the U.S., and France, observed higher frequency of
BWS cases after ART finding ~4, ~6, and ~3.2-fold increase, respectively [19,99,100]. The
majority (>90%) of BWS cases conceived by ART showed LOM at KCNQ1OT1:TSS DMR,
in comparison with 50% of BWS cases with this epimutation in the naturally conceived. In
2006, a preliminary British survey with 213 BWS, 38 TNDM, 384 AS, and 522 PWS observed
significant increased frequency of BWS in children conceived by ART [101]. In 2014, a
nationwide epidemiological study of the Japanese population revealed that the frequencies
of imprinting disorders after ART was 1.6% for AS, 1.5% for PWS, 8.6% for BWS, and
9.5% for SRS, respectively [97]. The results showed a slight increment in the frequency
of AS and PWS patients after ART, but 10-fold to 12-fold greater than expected in BWS
and SRS patients [97]. Finally, in 2019, another nationwide epidemiological study in Japan
found 3.44-, 4.46-, and 8.91-fold increased frequencies of PWS, BWS, and SRS after ART,
respectively [20]. Similarly, in livestock, LOM at IGF2R imprinting DMR has been described
after embryo culture, causing a rare overgrowth syndrome called large offspring syndrome
(LOS) with similar phenotypic features than BWS including overgrowth, macroglossia,
umbilical hernia, and visceromegalia [102].
The comparison of clinical phenotype and molecular features of ART (IVF and ICSI)
and non-ART children with sporadic BWS revealed lower frequency of exomphalos and
a higher risk of neoplasia [103]. This study also observed LOM at other imprinting con-
trol regions (ICRs) in 37.5% of ART and 6.4% of non-ART BWS IC2 cases. Likewise, the
study of DNA methylation changes at 23 gDMRs in CID-ART cases revealed a mixture
of mild hypermethylation and hypomethylation in maternal and paternal gDMRs [97].
These observations suggested MLIDs with cellular mosaicism, which might indicate errors
in the imprinting after fertilisation, probably by the impairment of imprinting mainte-
nance [97]. Likewise, another study performed in 2019 also observed incomplete and
more widespread DNA methylation variations in SRS cases conceived by ART than those
conceived naturally [20]. In this study, aberrant DNA methylation patterns appeared at
multiple imprinted regions in both maternal and paternal gDMRs, with both hyper and
hypomethylation events and in mosaic [20]. How ART can affect the protection of gDMRs
during epigenetic reprogramming is still unknown, however, mice studies revealed that
DNA methylation at imprinted regions might be particularly sensitive to culture medium
conditions [71,104,105]. For example, the exposure to 5% or 20% oxygen during in vitro
culture of IVF embryos produced abnormal DNA methylation and expression of imprinted
genes in the placentas [106]. In addition, mice embryos cultured in Whitten’s medium
showed biallelic expression of the H19 gene caused by loss of DNA methylation on the
paternal allele [104] and embryos cultured in vitro in different commercial culture media
showed loss of imprinting at H19, Snrpn, and Peg3 DMRs [107]. All these observations
indicate that the incidence of imprinting alterations in humans, animal models, and farm
animals after ART might be higher than expected by chance.
6. Epigenome Studies in Children Conceived by ART
The stress induced in the embryo by ART might affect DNA methylation at imprinted
regions, but the impact in the epigenome is still unclear. Table 2 summarises the epigenome
studies performed with methylation array platforms. The comparison of umbilical cord
blood and placenta DNA methylation profiles of 10 ART cases and eight naturally conceived
(NC) revealed 733 differentially methylated probes (DMPs) [108]. This study also detected.
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Table 2. Epigenome studies performed with methylation array platforms in individuals conceived by assisted reproductive technologies.
Cases Controls No. Cases No. Ctrls Sample Type Platform No. DMPs 1 iDMRs Affected Results Reference







ART-Placenta showed lower mean methylation and ART-cord blood higher. DNA
methylation differences associated with gene expression differences at both
imprinted and non-imprinted genes.
Katari et al., 2009







Significant differences in DNA methylation were enriched in certain types of
genomic locations and with greater variability and more hypomethylation.
Melamed et al., 2015





n.s. n.s. Significant differences in DNA methylation associated with IVF/ICSI culture
conditions and/or parental infertility were detected at metastable epialleles.
Imprinted genes are differentially methylated more often than expected by chance.
No differences between ICSI-frozen and intrauterine insemination.
Estill et al., 2016
IVF/
ICSI





Significant differences in DNA methylation but with small (β < 10%) or very small
(β < 1%) effect size. ICSI showed a significantly decreased DNA methylation age
at birth. DMPs enriched in CpG islands with low methylation values and in ICRs.
El Hajj et al., 2017
ART SC 23 41 cord blood Illumina® Infinium
Human
Methylation450 array 4
0 $ No significant difference in DNA methylation in ART. Significant differences found
between stochastic epigenetic variability and four multiple factor analysis dimensions
summarizing common phenotypic, behavioral or environmental factors.
Gentilini et al., 2018
ART SC 44 44 Placenta Illumina® Infinium
Human
Methylation450 array 4
0 ¥/84,270 ¥¥ GNAS, SGCE,
KCNQT1OT1,
BLCAP/ NNAT ¥¥
No significant difference in DNA methylation comparing ART with controls. The
comparison of ART outlier group with controls showed significant differences in
DNA methylation, enriched in loss of methylation of several imprinted genes.
IVF/ICSI showed distinct epigenetic profiles.
Choufani et al., 2019







2340 n.s. Significant difference in DNA methylation around birth. No difference found with
embryo culture. Epigenetic variation at birth mostly resolves by adulthood. No
significant association with imprinting regions but using relaxed threshold, 4% of
imprinting-related probes showed differential methylation at birth.
Novakovic et al., 2019
IVF/
ICSI
SC 87 70 cord blood Illumina® Infinium
Human
Methylation450 array 4
19 No significant association of ART with global methylation levels, imprinted loci
and meta-stable epialleles. No difference was found between IVF and ICSI. DMPs
map to genes related to brain function/development or genes connected to
conditions linked to subfertility.
Tobi et al., 2021
1 FDR < 0.05; 2 This platform interrogated 1536 CpGs; 3 This platform interrogated 27,578 CpGs; 4 This platform interrogated 485,000 CpGs; 5 This platform interrogated 850,000 CpGs; ¥ ART vs controls; ¥¥ ART
outlier group vs. controls; $ significance threshold genome-wide approach (p < 10−7); DMP, differentially methylated probes; iDMR, imprinting differentially methylated regions; IVF, in vitro fertilisation; ICSI,
intracytoplasmic sperm injection; ART, assisted reproductive technology; ICR, imprinting control regions; β, beta-value; n.s. not specified.an enrichment in certain genomic locations, in particular imprinted
regions and observed high variability [108]. The study of neonatal blood spots from 94 ART and 43 NC showed no global methylation alterations and an enrichment of alterations in imprinted genes and
metastable epialleles [109]. The comparison of cord blood from 123 ART and 53 NC identified 4730 DMPs, but with small (β < 10%) or very small (β < 1%) effect size [110]. This study also reported an
enrichment in CpG islands with low methylation values (0–20%) and located in imprinting control regions (ICRs) [110]. Interestingly, this study observed a significantly decreased DNA methylation age at birth,
approximately half a week behind, in the ICSI group. In contrast, a similar approach with 23 ART and 41 NC found no significant differences in children conceived by ART and children conceived naturally [111].
However, this work applied a more stringent significance threshold, genome-wide approach (p < 10−7) instead of p-value adjusted by FDR < 0.05. The authors of this work suggested that the number of stochastic
epigenetic variations induced by ART was not greater than the ones induced naturally in response to maternal behaviour or other common environmental factors [111]. Furthermore, the study of 44 placentas
from both children conceived by ART and children conceived naturally found no difference in DNA methylation after ART [112]. However, using principal component (PCA) of the whole placenta dataset
(414,320 CpGs), they determined an “outliers” group with 11 ART and four controls. This ART outlier group showed significant differences in DNA methylation and an enrichment in loss of methylation
of several imprinted genes [112]. Another study of cord blood from 87 ART and 70 NC found no global methylation changes after ART and identified 19 DMPs in the ART group [113]. This study found
no difference between IVF and ICSI or association with imprinted loci and meta-stable epialleles. Finally, the largest study until now explored the impact of epigenetic changes induced by ART at birth and
adulthood using a cohort of 193 ART and 86 NC (neonatal blood spots and adult blood from the same individual) [114]. This study identified 2340 DMPs at birth that mostly resolve by adulthood [114]. No
significant association was detected in imprinting regions, however, using a relaxed threshold, 4% of imprinting-associated probes showed differential methylation in neonatal blood.
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From these studies, we can conclude that no global DNA methylation changes were
observed in children conceived by ART in comparison with children conceived naturally.
DNA methylation changes detected were mild and widespread. The enrichment of DNA
methylation alterations at imprinted regions was detected in six of eight studies performed,
however, each study found different iDMRs affected with the exception of the GNAS locus.
The discrepancies found between studies can be explained by the low sample size analysed,
sample type, confounding factors used for correction, and threshold of significance used.
In addition, the array platform only partially covered some genomic regions, in particular
imprinted regions (for example, Illumina® Infinium Human Methylation450 array covered
IGF2:alt TSS DMR and MEG3/DLK1:IG DMR with only a single probe) and this will affect
the detection of methylation alterations. Additionally, the efficiency of the methylation
array platform to detect mild DNA methylation changes can be limited, as we observed
when comparing the Illumina® Infinium Human Methylation450 array and a hybridis-
ation custom bisulphite sequencing panel of imprinted regions [115]. However, not all
epigenome studies detected an enrichment of imprinting alterations; most of these studies
identified an apparent enrichment and pyrosequencing studies detected significant imprint-
ing alterations in children conceived by ART (cord blood and peripheral blood) [116,117].
The apparent alteration of DNA methylation at imprinted regions [108–110,112] might
explain why the frequency of congenital imprinting disorders in children conceived by ART
is greater than expected in the general population [20]. Besides, the imprinting alterations
reported were mild, suggesting some level of mosaicism, which might indicate that changes
occur after fertilisation, during the transition from zygote to blastocyst, when genomic
imprinting should be protected during epigenetic reprogramming.
Nevertheless, only a percentage of children conceived by ART showed phenotypic
outcomes and mild and widespread DNA methylation alterations [20]. In this context, the
identification of DNA methylation changes induced by ART could be problematic with
small sample size, methylation assays with low sensitivity and low number of probes
per region, and bioinformatic pipelines designed for other purposes. In this sense, the
approximation proposed by Choufani et al. (2019) with the identification of the ART
“outlier” group is promising [112]. The ART outlier group showed 84,270 DMPs with
an enrichment of alterations in imprinted regions in comparison with those naturally
conceived. In contrast, the comparison of the whole ART group with those naturally
conceived showed no significant alterations. Therefore, understanding the impact of ART
at the DNA methylation level will require the largest set of samples per subgroup (IVF/ICSI,
fresh/frozen) with similar culture conditions and adapted bioinformatic pipelines that
allow for the identification and study of this “outlier” ART group [112]. Studying the
effect of ART in genomic imprinting will require more sensitive approaches capable of
interrogating more CpGs per region and with high coverage. In this sense, two new
methods have been developed in the last years, Implicon [118] and ImprintSeq [115], which
are capable of interrogating 14 and 63 iDMRs, respectively, and with more than 100X
of coverage.
7. Implications in Long-Term Health
The comparison of epigenome changes induced by ART at birth and adulthood
showed that changes at birth mostly resolved in adulthood [114]. Nevertheless, the removal
of these changes in adulthood may not avoid the consequences of the adaptation induced in
the embryo to those changes that occurred during embryonic development. Embryos have
the ability to adapt and adjust to variations in their environment through developmental
plasticity [119]. The adaptations and alterations that occur during embryo and foetal
development may induce wide range of conditions and phenotypes in adulthood, as the
Developmental Origins of Health and Disease (DOHaD) hypothesis proposed [120,121].
Therefore, the environmental perturbations induced by ART in the embryo that can affect
developmental speed, metabolism, gene expression, and DNA methylation might influence
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the long-term health. However, it is still unknown if these alterations can translate into
adaptation responses that lead to long-term consequences (Figure 3).
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Some observations suggest that imprinted regions might be more susceptible than
other genomic regions to be affected by ART. The alteration of genomic imprinting during
embryonic development can affect embryo implantation and embryo development [71]
but the effect of these alterations in long-term health is still unclear. Mice studies have
revealed alterations in body composition, lipid metabolism, blood pressure, and glucose
tolerance by the restriction of imprinted genes at prenatal and early postnatal stages [122].
Likewise, the in vitro culture of mouse embryos has been associated with higher risk to
obesity, anxiety, and memory deficits [71,123]. In humans, individuals with congenital
imprinting disorders like BWS and SRS may also suffer some long-term health conditions.
For example, Silver–Russell Syndrome presents growth failure, severe feeding difficulties,
gastrointestinal problems, hypoglycaemia, body asymmetry, and scoliosis as well as motor
and speech delay [124]. In addition, SRS cases can describe increased risk of metabolic
disorders after rapid postnatal weight gain, premature adrenarche, early and rapid central
puberty, and insulin resistance [124]. In contrast, Beckwith–Wiedemann Syndrome shows
overgrowth, macroglossi , exomphalos, umbilical hernia, an childhood canc r [125].
In adulthood, individuals with BWS show in reased risk of neoplasia, infertility, and
renal anomalies [126]. Meanwhile, some individuals conceived by ART have shown
low birth weight, higher weight, height, and BMI in late infancy [38] and higher blood
pressure and fastin insulin levels, lower LDL, a d vascular dysfunction in a olescenc [54].
This developm nt de ay at birth probably c used by epigenetic alterations enric ed in
imprint d regions, followed by accelerat growth i late infancy and metabolic alterations
in adolescence, ma predispose them to chronic diseases like obesity, type 2 d abetes, and
cardiovascular disorder in adulthood [127,128].
Metabol c imp inting term was adopted by Waterland and Garza in 1999 [129] and
refers to the relationship between imprinting alterations during early embryonic develop-
ment and consequences later on in the development [130,131]. This hypothesis proposed
the epigenetic programming of metabolism during prenatal and postnatal periods as a
response to imprinting alterations that occurred during early evelopment. For exam-
ple, children from pregnant women exposed to famine during the Dutch Hunger Winter
showed loss of DNA methylation at the IGF2 imprinted gene locus and an increased risk
of diabetes, obesity, cardiovascular disease, and other health problems [132]. In this case,
pregnant women exposed to famine showed imprinting alterations in the embryo that af-
fected long-term health later on in the development. In the case of ART, the developmental
restriction during early or mid-gestation might be followed by accelerated placental and
foetal growth, which might lead to cardiometabolic alterations during adulthood [133].
Adolescents conceived by ART showed significant differences in growth kinetics, glucose
levels, fat deposition, and blood pressure in comparison with those conceived naturally by
subfertile parents [38,51,52]. The impact of ART in adulthood is still unknown, because the
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first IVF baby was born in 1978, however, all of these observations suggest that early-life
environmental conditions induced by ART, which might promote epigenetic changes and
imprinting alterations, may predispose long-term conditions (Figure 3).
8. Conclusions
ART procedures can induce stress in the embryo and affect the epigenome, but not
globally. Some authors have described mild widespread DNA methylation changes at
imprinted regions, which might suggest that the alterations occur after fertilisation by the
disruption of the maintenance of imprinting during epigenetic reprogramming. These
changes in imprinted regions might also induce epigenetic programming of metabolism
during the prenatal and postnatal periods with significant consequences in long-term health.
However, uncovering the real impact of ART on human health and the implication of the
genomic imprinting on it will require further and larger studies. Given the growing use of
ART, it is important to determine its impact in long-term health to improve procedures and
reduce risks.
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